Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 151 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1501 7.4 months Advanced, metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
St. Bartholomew's Hospital United Kingdom 2/2008
Treatment Details: Patients: This phase II study involved 24 patients with advanced, metastatic colorectal cancer. These patients had been treated with capecitabine or 5-fluoruracil (5-FU) previously. There
 
1502 7.4 months Metastatic breast cancer 4 Chemotherapy
Onkoloji Enstitusu, Istanbul Universitesi Turkey 8/2008
Treatment Details: Patients: This study involved 27 women with metastatic breast cancer. Their median age was 57, ranging from 37 to 76 years. They had all been previously treated with anthracycline and taxa
 
1503 7.4 months Advanced or metastatic NSCLC 5 Chemotherapy
University Hospital Groningen Netherlands 1/2005
Treatment Details: Patients: This Phase II study involved 108 patients. The patients were divided into two groups. 56 patients were assigned to Group A. The median age of Group A was 59, and twelve were wom
 
1504 7.4 months Recurrent malignant gliomas 4 Chemotherapy
Emory University School of Medicine United States 8/2003
Treatment Details: Patients: This Phase I study involved 40 patients with recurrent malignant gliomas. Thirty-four patients had glioblastoma multiforme, five had anaplastic astrocytoma, and one patient had an
 
1505 7.3 months hepatocellular carcinoma (metastatic) 4 Chemotherapy
Samsung Medical Center Korea 11/2004
Treatment Details: Patients: This Phase II study involved a total of 42 patients with metastatic hepatocellular carcinoma. There were 36 men and 6 women and the median age was 45 years. Of the 42 patients, 3
 
1506 7.3 months Advanced NSCLC 4 Chemotherapy
Bellaria Hospital Italy 7/2005
Treatment Details: Patients: This Phase II study involved 60 patients with advanced (non-small-cell lung cancer. Metastatic sites included liver, brain, lymph nodes, and bone. Forty-three patients were men,
 
1507 7.3 months Advanced hepatocellular carcinoma 5 Biologic therapy
Chang Gung Memorial Hospital Taiwan Region 9/2010
Treatment Details: Patients: This study involved 71 patients with advanced hepatocellular carcinoma. The median patient age was 55 years and 83.1% were male. Treatment: Patients in this study were given
 
1508 7.3 months Metastatic melanoma 4 Chemotherapy
University of California Davis Cancer Center United States 10/2010
Treatment Details: Patients: This study involved 17 metastatic melanoma patients with a median age of 53 years (range 34-85) and 35% male. Treatment: Patients in this study received a chemotherapy agent c
 
1509 7.3 months Advanced hepatocellular carcinoma 5 Biologic therapy
Chemotherapy
Queen Mary Hospital China 11/2010
Treatment Details: Patients: This study involved 27 patients with advanced hepatocellular carcinoma. The median age was 52 years and 92.6% were male. Treatment: Patients in this study were given a combin
 
1510 7.3 months Malignant pleural mesothelioma 5 Chemotherapy
Kinki University School of Medicine Japan 5/2008
Treatment Details: Patients: This study involved 25 patients with malignant pleural mesothelioma who had not received prior chemotherapy. Of these, 22 were male, and the median age was 61 years. Treatment
 
Page 151 of 187  | Previous Page  | Next Page